These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Designing dual inhibitors of Mdm2/MdmX: Unexpected coupling of water with gatekeeper Y100/99. Lee XA; Verma C; Sim AYL Proteins; 2017 Aug; 85(8):1493-1506. PubMed ID: 28425639 [TBL] [Abstract][Full Text] [Related]
26. Evolution in non-peptide α-helix mimetics on the road to effective protein-protein interaction modulators. Algar S; Martín-Martínez M; González-Muñiz R Eur J Med Chem; 2021 Feb; 211():113015. PubMed ID: 33423841 [TBL] [Abstract][Full Text] [Related]
27. Non-naturally Occurring Helical Molecules Can Interfere with p53-MDM2 and p53-MDMX Protein-Protein Interactions. Su A; Wang S; Sada A; Otani Y; Zhai L; Liu X; Sayama M; Ohki R; Ohwada T Chem Pharm Bull (Tokyo); 2019; 67(10):1139-1143. PubMed ID: 31582633 [TBL] [Abstract][Full Text] [Related]
28. Stapled peptides with improved potency and specificity that activate p53. Brown CJ; Quah ST; Jong J; Goh AM; Chiam PC; Khoo KH; Choong ML; Lee MA; Yurlova L; Zolghadr K; Joseph TL; Verma CS; Lane DP ACS Chem Biol; 2013 Mar; 8(3):506-12. PubMed ID: 23214419 [TBL] [Abstract][Full Text] [Related]
29. Trp53 regulates Notch 4 signaling through Mdm2. Sun Y; Klauzinska M; Lake RJ; Lee JM; Santopietro S; Raafat A; Salomon D; Callahan R; Artavanis-Tsakonas S J Cell Sci; 2011 Apr; 124(Pt 7):1067-76. PubMed ID: 21402876 [TBL] [Abstract][Full Text] [Related]
30. Abnormal MDMX degradation in tumor cells due to ARF deficiency. Li X; Gilkes D; Li B; Cheng Q; Pernazza D; Lawrence H; Lawrence N; Chen J Oncogene; 2012 Aug; 31(32):3721-32. PubMed ID: 22120712 [TBL] [Abstract][Full Text] [Related]
31. Determinants of specificity of MDM2 for the activation domains of p53 and p65: proline27 disrupts the MDM2-binding motif of p53. Zondlo SC; Lee AE; Zondlo NJ Biochemistry; 2006 Oct; 45(39):11945-57. PubMed ID: 17002294 [TBL] [Abstract][Full Text] [Related]
32. De novo designed library of linear helical peptides: an exploratory tool in the discovery of protein-protein interaction modulators. Bonache MÁ; Balsera B; López-Méndez B; Millet O; Brancaccio D; Gómez-Monterrey I; Carotenuto A; Pavone LM; Reille-Seroussi M; Gagey-Eilstein N; Vidal M; de la Torre-Martinez R; Fernández-Carvajal A; Ferrer-Montiel A; García-López MT; Martín-Martínez M; de Vega MJ; González-Muñiz R ACS Comb Sci; 2014 May; 16(5):250-8. PubMed ID: 24725184 [TBL] [Abstract][Full Text] [Related]
33. Autoinhibition of MDMX by intramolecular p53 mimicry. Chen L; Borcherds W; Wu S; Becker A; Schonbrunn E; Daughdrill GW; Chen J Proc Natl Acad Sci U S A; 2015 Apr; 112(15):4624-9. PubMed ID: 25825738 [TBL] [Abstract][Full Text] [Related]
34. Substituted 1,4-benzodiazepine-2,5-diones as alpha-helix mimetic antagonists of the HDM2-p53 protein-protein interaction. Cummings MD; Schubert C; Parks DJ; Calvo RR; LaFrance LV; Lattanze J; Milkiewicz KL; Lu T Chem Biol Drug Des; 2006 Mar; 67(3):201-5. PubMed ID: 16611213 [TBL] [Abstract][Full Text] [Related]
35. Simultaneous measurement of p53:Mdm2 and p53:Mdm4 protein-protein interactions in whole cells using fluorescence labelled foci. Frosi Y; Inoue K; Ramlan SR; Lane DP; Watanabe T; Brown CJ Sci Rep; 2019 Nov; 9(1):17933. PubMed ID: 31784573 [TBL] [Abstract][Full Text] [Related]
36. A site-directed mutagenesis study of the MdmX RING domain. Egorova O; Mis M; Sheng Y Biochem Biophys Res Commun; 2014 May; 447(4):696-701. PubMed ID: 24755078 [TBL] [Abstract][Full Text] [Related]
37. d-Amino acid mutation of PMI as potent dual peptide inhibitors of p53-MDM2/MDMX interactions. Li X; Liu C; Chen S; Hu H; Su J; Zou Y Bioorg Med Chem Lett; 2017 Oct; 27(20):4678-4681. PubMed ID: 28916339 [TBL] [Abstract][Full Text] [Related]